AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 104 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $602,000 | -56.8% | 9,954,092 | +20.0% | 0.00% | – |
| Q2 2022 | $1,393,000 | -68.2% | 8,291,965 | -10.9% | 0.00% | – |
| Q1 2022 | $4,375,000 | -16.8% | 9,307,338 | +0.8% | 0.00% | – |
| Q4 2021 | $5,261,000 | -65.7% | 9,229,516 | -0.2% | 0.00% | – |
| Q3 2021 | $15,356,000 | +0.1% | 9,250,467 | +0.7% | 0.00% | – |
| Q2 2021 | $15,340,000 | +21.3% | 9,186,107 | +22.8% | 0.00% | – |
| Q1 2021 | $12,644,000 | +12.3% | 7,481,658 | +5.7% | 0.00% | – |
| Q4 2020 | $11,255,000 | +96.0% | 7,078,725 | +18.0% | 0.00% | – |
| Q3 2020 | $5,742,000 | +68.7% | 6,000,123 | +12.3% | 0.00% | – |
| Q2 2020 | $3,404,000 | +53.1% | 5,344,638 | -0.2% | 0.00% | – |
| Q1 2020 | $2,223,000 | -28.8% | 5,352,988 | 0.0% | 0.00% | – |
| Q4 2019 | $3,121,000 | +16.4% | 5,352,988 | +0.0% | 0.00% | – |
| Q3 2019 | $2,682,000 | +47.2% | 5,351,742 | +13.9% | 0.00% | – |
| Q2 2019 | $1,822,000 | -32.3% | 4,698,708 | -1.9% | 0.00% | – |
| Q1 2019 | $2,691,000 | +61.0% | 4,787,396 | +13.1% | 0.00% | – |
| Q4 2018 | $1,671,000 | -13.9% | 4,233,365 | +10.8% | 0.00% | – |
| Q3 2018 | $1,941,000 | -74.1% | 3,819,564 | +12.3% | 0.00% | – |
| Q2 2018 | $7,481,000 | -24.5% | 3,400,473 | +16.6% | 0.00% | – |
| Q1 2018 | $9,913,000 | +5.3% | 2,915,653 | +26.0% | 0.00% | – |
| Q4 2017 | $9,417,000 | +1078.6% | 2,313,849 | +77.0% | 0.00% | – |
| Q3 2017 | $799,000 | +6.1% | 1,307,185 | -9.5% | 0.00% | – |
| Q2 2017 | $753,000 | -48.3% | 1,444,091 | -20.7% | 0.00% | – |
| Q1 2017 | $1,456,000 | -10.6% | 1,820,572 | +0.6% | 0.00% | – |
| Q4 2016 | $1,629,000 | +9.0% | 1,809,108 | -10.3% | 0.00% | – |
| Q3 2016 | $1,494,000 | -35.5% | 2,017,818 | +12.4% | 0.00% | – |
| Q2 2016 | $2,316,000 | -38.4% | 1,795,319 | +7.4% | 0.00% | – |
| Q1 2016 | $3,761,000 | -33.0% | 1,671,421 | +4.2% | 0.00% | – |
| Q4 2015 | $5,616,000 | -97.1% | 1,604,436 | -79.3% | 0.00% | -100.0% |
| Q3 2015 | $190,747,000 | +5240.1% | 7,758,217 | +414.7% | 0.01% | – |
| Q2 2015 | $3,572,000 | -66.8% | 1,507,469 | +5.4% | 0.00% | -100.0% |
| Q1 2015 | $10,766,000 | +132.4% | 1,429,654 | +5.9% | 0.00% | – |
| Q4 2014 | $4,632,000 | +0.2% | 1,350,365 | +3.1% | 0.00% | – |
| Q3 2014 | $4,624,000 | -58.5% | 1,309,898 | -1.8% | 0.00% | -100.0% |
| Q2 2014 | $11,141,000 | +32.5% | 1,334,282 | +0.8% | 0.00% | 0.0% |
| Q1 2014 | $8,409,000 | +13.5% | 1,324,337 | +27.5% | 0.00% | 0.0% |
| Q4 2013 | $7,407,000 | -2.2% | 1,038,841 | +2.9% | 0.00% | 0.0% |
| Q3 2013 | $7,570,000 | +30.2% | 1,009,337 | +0.2% | 0.00% | 0.0% |
| Q2 2013 | $5,813,000 | – | 1,007,439 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|